Sonrai, a leading AI precision medicine company accelerating the development of therapeutics through advanced analytics, and Paige, a leader in next-generation AI technology, have announced a strategic partnership to better enable biopharma researchers, pathologists, and clinicians to harness cutting-edge AI capabilities for precision medicine research and development.
By integrating Paige’s state-of-the-art foundation models with Sonrai’s intuitive cloud-based data analysis and bioinformatics platform, the partnership makes AI, machine learning, and multi-modal data integration accessible to non-technical users, creating the ability for more organizations to access a wide range of critical R&D needs without requiring deep AI expertise. This important collaboration will help bring a powerful set of solutions to the market that can accelerate drug discovery, biomarker identification, targeted therapeutics and precision medicine applications.
Sonrai’s flagship product, Sonrai Discovery, expedites the identification and development of therapeutic targets, improving patient outcomes through AI. The Sonrai Discovery platform supports the integration and analysis of diverse datasets, including multi-omics (such as transcriptomics, proteomics, etc.), imaging, and clinical data. Through this partnership, the platform will incorporate Paige’s multi-modal foundation model suite, allowing biotechnology and pharmaceutical companies to manage and analyze their precision medicine data while supporting no-code applications for non-technical users. Paige’s Foundation models are considered to be state-of-the-art, built on enormous pathologic and genomic data sets, generalizable, and they are already accelerating the development of a growing portfolio of prognostic and predictive markers.
“We are thrilled to partner with Paige to unlock new possibilities for biopharma researchers and clinicians”, said Prof. Darragh McArt, CEO and Founder, Sonrai Analytics. “By combining our Sonrai Discovery platform with Paige’s foundation models, we are making AI and machine learning more accessible, enabling researchers to extract deeper insights from their data and accelerate precision medicine breakthroughs.”
Related: Tech for Good: Belfast-based ESO employees contribute to AI-powered healthcare innovation
Subscribe to the Sync NI newsletter for all the latest technology news, jobs and upcoming events in Northern Ireland.
Visit Sync NI online for the latest technology news in Northern Ireland.
"Our goal has always been to build best-in-class AI technology that is accessible to as many users as possible”, said Razik Yousfi, CEO and CTO at Paige. “Our partnership with Sonrai further drives this vision, providing a wider audience of researchers access to Paige's Foundation Models through the Sonrai Discovery Platform. This will ultimately accelerate Pharma research and discovery globally, accelerating the new wave of AI driven biomarkers in cancer and other diseases.”
This partnership represents a significant step toward making AI-powered research more accessible, advancing the development of novel treatments and improving patient outcomes.
Sonrai and Paige will host an exclusive live webinar on 29 May 2025, titled “Unlocking Prognostic Biomarkers: Integrating Imaging and Omics with Foundation Models.” The session will explore how the convergence of imaging and omics data with advanced AI foundation models is accelerating biomarker discovery and shaping the future of precision medicine. Attendees will gain insight into real-world applications, see a live demonstration of the technology in action, and have the opportunity to engage directly with industry experts during an interactive Q&A. Registration is now open at https://bit.ly/foundation-models-webinar.
Read the latest edition, Spring 2025, of Sync NI here completely free of charge.
Subscribe to the Sync NI newsletter for all the latest technology news, jobs and upcoming events in Northern Ireland.
Visit Sync NI online for the latest technology news in Northern Ireland.
